XML 83 R67.htm IDEA: XBRL DOCUMENT v3.25.0.1
Earnings Per Share - Schedule of Reconciliation of Numerator and Denominator of Basic and Diluted Earnings per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Numerator:      
Net loss attributable to Surgery Partners, Inc. $ (168.1) $ (11.9) $ (54.6)
Weighted average common shares outstanding:      
Basic (shares) 126,122 125,613 91,952
Diluted (shares) [1] 126,122 125,613 91,952
Net loss per share attributable to common stockholders:      
Basic (in USD per share) $ (1.33) $ (0.09) $ (0.59)
Diluted (in USD per share) [1] $ (1.33) $ (0.09) $ (0.59)
Stock options      
Net loss per share attributable to common stockholders:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 1,133 1,246 1,459
Restricted shares      
Net loss per share attributable to common stockholders:      
Dilutive securities outstanding not included in the computation of diluted loss per share as their effect is antidilutive (shares) 372 263 679
[1] The impact of potentially dilutive securities for all periods was not considered because the effect would be anti-dilutive.